Tolvaptan
- Generic Name
- Tolvaptan
- Brand Names
- Jinarc, Jynarque 45/15 Carton, Samsca, Tolvaptan Accord, Xeljanz
- Drug Type
- Small Molecule
- Chemical Formula
- C26H25ClN2O3
- CAS Number
- 150683-30-0
- Unique Ingredient Identifier
- 1E2497LPNY
Overview
Tolvaptan is used to treat low blood sodium levels (hyponatremia) associated with various conditions like congestive heart failure, cirrhosis, and syndrome of inappropriate antidiuretic hormones (SIADH). FDA approved on May 19, 2009.
Background
Tolvaptan is used to treat low blood sodium levels (hyponatremia) associated with various conditions like congestive heart failure, cirrhosis, and syndrome of inappropriate antidiuretic hormones (SIADH). FDA approved on May 19, 2009.
Indication
Treatment of symptomatic and resistant to fluid restriction euvolemic or hypervolemic hyponatremia associated with congestive heart failure, SIADH, and cirrhosis.
Associated Conditions
- Autosomal Dominant Polycystic Kidney Disease （ADPKD)
- Symptomatic euvolemic Hyponatremia
- Symptomatic hypervolemic Hyponatremia
Clinical Trials
FDA Approved Products
XELJANZ XR
Manufacturer:Pfizer Laboratories Div Pfizer Inc
Route:ORAL
Strength:22 mg in 1 1
Approved: 2023/05/23
NDC:0069-0502
JYNARQUE
Manufacturer:Otsuka America Pharmaceutical, Inc.
Route:ORAL
Strength:15 mg in 1 1
Approved: 2020/10/23
NDC:59148-082
Tolvaptan
Manufacturer:Camber Pharmaceuticals, Inc.
Route:ORAL
Strength:30 mg in 1 1
Approved: 2022/09/05
NDC:31722-869
Tolvaptan
Manufacturer:Camber Pharmaceuticals, Inc.
Route:ORAL
Strength:15 mg in 1 1
Approved: 2022/09/05
NDC:31722-868
tolvaptan
Manufacturer:Apotex Corp.
Route:ORAL
Strength:30 mg in 1 1
Approved: 2023/12/15
NDC:60505-4318
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath